Novel biomarkers distinguish heart failure with preserved vs reduced ejection fraction. [PDF]
Hage C +6 more
europepmc +1 more source
Baroreflex Activation Therapy in HFrEF Patients: Anti-Inflammatory Effects and Autonomic Restoration. [PDF]
Bekiaridou A +11 more
europepmc +1 more source
Circulating Omentin Levels in Heart Failure: A Case-Control Study. [PDF]
Currò D +6 more
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonists Across the Heart Failure Spectrum: A Systematic Review and Meta-Analysis. [PDF]
Muller Ferreira V, Ayres Muller V.
europepmc +1 more source
Amino Acid-Derived Metabolic Signature Across Stages of Systolic Dysfunction: Derivation and Internal Evaluation of the HASI (Heart Failure Amino Acid-Derived Systolic Index)-40 Index. [PDF]
Krasińska B +10 more
europepmc +1 more source
Beyond Breathlessness Intensity: A Prospective Psychometric Validation of the Multidimensional Dyspnea Profile in Heart Failure with Reduced and Mildly Reduced Ejection Fraction. [PDF]
Aldhahi MI, Nazer RI, Albarrati AM.
europepmc +1 more source
Vericiguat: A New Horizon for Heart Failure Treatment. [PDF]
Carbonaro C +9 more
europepmc +1 more source
The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions. [PDF]
Ma X +8 more
europepmc +1 more source

